Janet C Blanks

Title: Janet C Blanks: Innovator in Ocular Treatments

Introduction

Janet C Blanks is a prominent inventor based in Boca Raton, FL (US). She has made significant contributions to the field of ocular treatments, holding a total of 3 patents. Her innovative work focuses on methods to prevent degeneration of photoreceptor cells and pathological neovascularization in the eye.

Latest Patents

One of her latest patents is a method for retinopathy treatment, which involves administering a pharmaceutical composition containing a sulindac agent to the eye of a mammalian subject. This method aims to prevent degeneration of photoreceptor cells, which is crucial for maintaining vision. Another notable patent involves materials and methods for treating pathological neovascularization in the eye. This invention provides effective strategies to prevent the over-proliferation of blood vessels, particularly beneficial for conditions such as age-related macular degeneration (AMD), retinopathy of prematurity (ROP), and diabetic retinopathy. The use of gene therapy in her methods represents a significant advancement in ocular treatment options.

Career Highlights

Throughout her career, Janet has worked with notable organizations, including Florida Atlantic University Research Corporation and Chs Pharma, Inc. Her work in these institutions has allowed her to develop and refine her innovative approaches to eye care.

Collaborations

Janet has collaborated with esteemed colleagues such as Howard Malcolm Prentice and C Kathleen Dorey. These partnerships have contributed to her success and the advancement of her research in ocular health.

Conclusion

Janet C Blanks is a trailblazer in the field of ocular treatments, with her patents paving the way for new therapeutic methods. Her dedication to innovation continues to impact the lives of those affected by ocular conditions.